Telomere Diagnostics, Inc.

Telomere Diagnostics, Inc. is a high throughput, CLIA-certified clinical diagnostics laboratory, established in 2010. Specializing in COVID-19 testing, the company offers national scale and comprehensive clinical and digital solutions, enabling a seamless collection, testing, and reporting process. Their current offering includes saliva and nasal PCR testing for COVID-19. The company operates in the Biopharma, Biotechnology, and Health Care industries. Despite the lack of specific information regarding the company's headquarters and last investment, the firm's focus on COVID-19 testing solutions positions it within the critical healthcare sector, a key consideration for potential investors.